Skip to main content

ASCO Highlights

ASCO Highlights, Prostate Cancer

Continuous Treatment with Enzalutamide and Docetaxel Reduces the Risk for Progression in Patients with Metastatic Castration-Resistant Prostate Cancer

Meeting Highlights

Multiple Myeloma, ASCO Highlights

New CAR T-Cell Therapy Produces Durable Responses in Relapsed or Refractory Multiple Myeloma

Wayne Kuznar

Meeting Highlights

Biosimilars, ASCO Highlights

Rapid Biosimilar Adoption Possible in Community Oncology Practice

Chase Doyle

Meeting Highlights

Lung Cancer, ASCO Highlights

Atezolizumab Extends Disease-Free Survival in PD-L1−Positive Early-Stage NSCLC

Phoebe Starr

Meeting Highlights

Prostate Cancer, ASCO Highlights

¹⁷⁷Lu-PSMA-617 Prolongs Survival in Patients with Metastatic Castration-Resistant Prostate Cancer

Phoebe Starr

Meeting Highlights

ASCO Highlights

ASCO 2020 Lung Cancer Highlights

Meeting Highlights

ASCO Highlights

Clinical Activity of the RET Inhibitor Pralsetinib (BLU-667) in Patients with RET-Altered Solid Tumors

Meeting Highlights

ASCO Highlights

Clinical Activity of Pralsetinib (BLU-667) in Patients with Advanced RET Fusion–Positive NSCLC

Meeting Highlights

ASCO Highlights

AcceleRET Lung: A Phase 3 Study of Pralsetinib in Patients with RET Fusion–Positive Metastatic NSCLC

Meeting Highlights

ASCO Highlights

Efficacy of Capmatinib in Second-Line Treatment of Patients with METex14-Mutated NSCLC

1
2
3
4
5

Page 2 of 5
Results 11 - 20 of 42